Global Life Science Ventures Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

Due diligence and investment criteria

The investment process of GLSV is designed to create value for the partnership. Evaluation criteria and due diligence may vary according to the stage of development of each company. Typically it will include an assessment of:

  • the scientific or technological concept
  • the unique selling proposition
  • the international competitiveness
  • the track record and strength of the management team;
  • the market and competitive position;
  • technological advantage and intellectual property protection;
  • the past and current operating performance of the company depending on the stage of development;
  • its management controls and reporting systems;
  • future resource requirements.
  • different options for exits.

See Portfolio Companies.